Patents by Inventor Jochen G. Raimann

Jochen G. Raimann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of controlling diffusive sodium transport in dialysis
    Patent number: 8518260
    Abstract: A method of controlling diffusive sodium transport from the dialysate solution to the blood of a patient undergoing hemodialysis treatment or from the blood to the dialysate solution includes calculating SNa+average, an average of the patient's historic serum sodium concentrations, and estimating SNa+estimated, the patient's pre-dialysis serum sodium concentration, based on the average of the patient's measured historic pre-dialysis serum sodium concentrations, SNa+measured. The method enables adjusting DNa+, the sodium concentration of the dialysate solution, based on the average of the patient's historic serum sodium concentrations, SNa+average, if needed, and performing the dialysis treatment of the patient using a dialysate solution containing a sodium concentration DNa+.
    Type: Grant
    Filed: October 1, 2010
    Date of Patent: August 27, 2013
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Jochen G. Raimann, Erik Lars Penne, Stephan Thijssen, Peter Kotanko, Nathan W. Levin
  • METHOD OF CONTROLLING DIFFUSIVE SODIUM TRANSPORT IN DIALYSIS
    Publication number: 20110079558
    Abstract: A method of controlling diffusive sodium transport from the dialysate solution to the blood of a patient undergoing hemodialysis treatment or from the blood to the dialysate solution includes calculating SNa+average, an average of the patient's historic serum sodium concentrations, and estimating SNa+estimated, the patient's pre-dialysis serum sodium concentration, based on the average of the patient's measured historic pre-dialysis serum sodium concentrations, SNa+measured. The method enables adjusting DNa+, the sodium concentration of the dialysate solution, based on the average of the patient's historic serum sodium concentrations, SNa+average, if needed, and performing the dialysis treatment of the patient using a dialysate solution containing a sodium concentration DNa+.
    Type: Application
    Filed: October 1, 2010
    Publication date: April 7, 2011
    Applicant: Fresenius Medical Care Holdings, Inc.
    Inventors: Jochen G. Raimann, Erik Lars Penne, Stephan Thijssen, Peter Kotanko, Nathan W. Levin